The settlement’s details have not been publicly disclosed; however Peipert has agreed to not bring any additional legal action against Roche. Roche will also not maintain guilt as a result of this case. Peipert filed the suit in 2003 after claiming the drug was the cause for his severe side effects and IBD. He was prescribed the drug by Dr. Daniel Goran, another defendant, who also settled with Peipert separately.
Roche has lost each of the six cases that have been heard in trials to this point, and the verdicts have cost the world’s seventh-largest pharmaceutical manufacturer more than $56 million. An Alabama man, Andrew McCarrell, is the recipient of the largest settlement to date, having been rewarded a payout of more than $26 million after a trial in New Jersey court in February.
Roche pulled Accutane from the market in 2009, citing increased generic competition as the reason to discontinue manufacturing and distributing the drug. However, the company still produces and markets similar versions under other names.
Accutane is known to have several potentially fatal side effects including colitis, Crohn's Disease, severe depression, suicidal thoughts, inflammatory bowel disease, liver damage, birth defects, and other health complications. It is not uncommon for Accutane patients who suffer long term effects to file lawsuits in regards to compensation. However, there is a plentiful amount of information available to warn patients about risks associated with taking the drug.
Specific requirements have also been put in place for medical doctors and dermatologists who prescribe the drug. Informational sessions are given to patients and paperwork is required to be read and signed before the drug is administered. Patients are well-informed of potential side effects or illnesses that may appear as a result of taking Accutane, and receive a patient identification card through a government system that is used when picking up a prescription.
0 comments:
Post a Comment